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INTRODUCTION 
Over the last thirty years, once abundant wild salmon populations in 
the Pacific and Atlantic Oceans have declined to a mere fraction of their 
historic levels. As of 2016, salmon populations in Washington State’s 
Columbia River region are either failing to make any progress towards 
recovery or showing very little signs of improvement; Puget Sound salmon 
are only getting worse.1 In the Gulf of Maine, salmon populations dropped 
from five-hundred spawning adults in 1995 to less than fifty adults in 
1999.2 Atlantic salmon, Salmo salar, were first designated as 
“endangered”3 in November 2000—the Fish and Wildlife Service (FWS) 
expanded the listing nine years later to include critical habitat along the 
coast of Maine as a result of little improvement to the population’s 
numbers.4 In the Pacific Ocean, FWS classified four significant salmon 
species as endangered for protection under the Endangered Species Act 
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 1. Governor’s Salmon Recovery Office, State of Salmon in Watersheds 2016, WASH. ST. 
RECREATION & CONSERVATION OFF., http://stateofsalmon.wa.gov/governors-report-2016/ [https:// 
perma.cc/6F3J-FKWE]. 
 2. Endangered and Threatened Species; Final Endangered Status for a Distinct Population 
Segment of Anadromous Atlantic Salmon (Salmo salar) in the Gulf of Maine, 50 C.F.R. § 224.101 
(June 19, 2009). 
 3. Pursuant to the ESA, the term “endangered” means any species which is in danger of 
extinction throughout all or a significant portion of its range other than a species of the Class Insecta 
determined by the Secretary to constitute a pest whose protection under the provisions of this Act 
would present an overwhelming and overriding risk to man. 16 U.S.C. § 1532(6). 
 4. Atlantic salmon (Salmo salar), NOAA FISHERIES, http://www.fisheries.noaa.gov/ 
pr/species/fish/atlantic-salmon.html [https://perma.cc/P7BF-3HWM]. 
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(ESA) beginning in 1991;5 of the four, only one species has been upgraded 
to the less severe “threatened” status.6 As a keystone species in the Pacific 
Northwest, a healthy salmon population supports an entire ecosystem of 
species including grizzly bears, bald eagles, and orca whales—all of which 
have been or are considered endangered7—and as the salmon population 
continues to decline, other species will follow suit.8 Protecting one of the 
last great salmon ecosystems is a daunting task requiring the collaboration 
of conservationists, policymakers, scientists, and many others. 
In response to the global demand for salmon tripling since the 1980s 
and the declining wild salmon population, farmed salmon and aquaculture 
facilities have gained popularity in the United States.9 In 2013, farmed 
salmon exceeded 70% of total salmon consumed globally.10 Furthermore, 
the thirty-three hatcheries devoted to salmon production in the United 
States have helped mask the low-level return of wild salmon returning 
each year; scientists have recorded as little as 10% of Chinook salmon in 
the fall spawning season were born in the wild.11 Biologist Rachel Johnson 
qualified the situation well, stating: 
[w]hen you use the raw fish counts, it looks like the population is 
doing well. But if you look at the number of fish that are produced in 
the wild and return to spawn in the wild, and you follow through the 
                                                     
 5. The ESA currently protects four salmon species native to Puget Sound in Washington State: 
Chinook (Oncorhynchus tshawtscha), Chum (Oncorhynchus keta), Coho (Oncorhynchus kisutch) and 
Sockeye (Oncorhynchus nerka). In November 1991, the Sockeye salmon was first listed as 
“endangered” in the Snake River; beginning in 1992, the Chinook salmon was listed as “threatened”; 
in 1999, the distinct population segment of the Upper Columbia River spring run was listed as 
“endangered”; beginning in 1999, Chum salmon was listed as “threatened.” Salmon Species Listed 
Under the Federal Endangered Species Act, WASH. ST. RECREATION & CONSERVATION OFF., 
http://www.rco.wa.gov/salmon_recovery/listed_species.shtml [https://perma.cc/XP3B-M3LX]. 
 6. The term “threatened” means any species that is likely to become endangered within the 
foreseeable future throughout all or a significant portion of its range. 16 U.S.C. § 1532(20). 
 7. Endangered and Threatened Wildlife and Plants; Draft Revised Supplement to the Grizzly 
Bear Recovery Plan, 78 Fed. Reg. 17,708-09 (Mar. 22, 2013); Determination of Certain Bald Eagle 
Populations as Endangered or Threatened, 43 Fed. Reg. 6,230-33 (Feb. 14, 1978); NMFS: Endangered 
Status for Southern Resident Killer Whales, 70 Fed. Reg. 69,903-12 (Nov. 18, 2005). 
 8. See Guido Rahr on Salmon Strongholds, TEDX TALK (Jan. 9, 2015), 
https://vimeo.com/116385054 [https://perma.cc/J6HC-M9FD]; Guido Rahr, Why Protect Salmon, 
WILD SALMON CTR., https://www.wildsalmoncenter.org/work/why-protect-salmon/ [https:// 
perma.cc/EGK2-Q3E8]. 
 9. See Farmed Salmon, WORLD WILDLIFE FUND, http://www.worldwildlife.org/industries/ 
farmed-salmon [https://perma.cc/ZLD8-XZE9]. 
 10. In 2013, Americans consumed 353,000 tons of the farmed salmon. See Brian Clark Howard, 
Salmon Farming Gets Leaner and Greener, NAT’L GEOGRAPHIC (Mar. 19, 2014), http://news. 
nationalgeographic.com/news/2014/03/140319-salmon-farming-sustainable-aquaculture/ [https:// 
perma.cc/7BWR-Q7AU]. 
 11. See Tim Stephens, Hatchery Fish Mask the Decline of Wild Salmon Populations, U. CAL. 
SANTA CRUZ (Feb. 8, 2012), http://news.ucsc.edu/2012/02/hatchery-salmon.html [https://perma.cc/ 
BL2T-DHUJ]. 
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cycle, you see that the wild fish don’t survive at a high enough rate 
to replace their parents. So the habitat is not supporting a sustainable 
wild population.12 
Still, the shift to dependency on farmed salmon has not been enough 
to replace the wild salmon runs.13 Innovation and technology in the prior 
decade have led us to AquAdvantage—the first-of-its-kind, genetically 
engineered salmon produced by AquaBounty Technologies, Inc.14 The 
biotech company claims that AquAdvantage salmon is better for the 
environment and for consumers, while also boasting a low-impact fish 
farming system that may result in healthier salmon.15 The new take on 
traditional salmon aquaculture adds a growth hormone into the genetic 
makeup of Atlantic salmon in order to accelerate the growth period from 
three years to a swift eighteen months.16 Moreover, the AquAdvantage 
salmon averages a final weight of 6,000 grams, almost a third heavier than 
a wild Atlantic salmon.17 While AquaBounty implements farming 
practices that improve upon the negative impacts of aquaculture and stock 
ponds,18 the already endangered salmon population faces the risk of the 
dominate AquAdvantage salmon compromising the Atlantic salmon’s 
chance at survival. 
The United States Food and Drug Administration (FDA) has asserted 
authority to rule on and approve genetically engineered (GE) salmon by 
classifying AquAdvantage as a “new animal drug.”19 Following an almost 
twenty year review process, the FDA issued a Final Rule on November 
24, 2015 granting the use of AquAdvantage salmon for sale in the U.S.20 
Despite the fact that AquAdvantage has yet to be incorporated into the 
market for consumption, environmental advocates wasted no time filing 
                                                     
 12. Id. 
 13. The most recent report regarding the salmon returns to the Puget Sound area had mixed 
reviews. While some areas were told to expect strong levels, others are closed to non-tribal fishing 
until further notice. Despite the varying salmon returns across the state, the levels are still nowhere 
near the historical levels and are being closely monitored. RYAN LOTHROP & MARK BALTZELL, WASH. 
DEP’T FISH & WILDLIFE, 2017 PUGET SOUND SALMON FORECASTS: COHO AND CHINOOK (Mar. 01, 
2017), http://wdfw.wa.gov/fishing/northfalcon/2017/2017_salmon_forecasts_fact_sheet.pdf [https:// 
perma.cc/EQW3-5TQW]. 
 14. See Sustainable, AQUABOUNTY, https://aquabounty.com/sustainable/ [https://perma.cc/ 
SV7X-TV5G]. 
 15. Id. 
 16. Id. 
 17. Id. 
 18. Id. 
 19. 21 C.F.R. § 510 (2015). 
 20. FDA Final Rule, New Animal Drugs in Genetically Engineered Animals, 80 Fed. Reg. 
73,104 (Nov. 24, 2015). 
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legal action to repeal the ruling.21AquAdvantage salmon has entered the 
production phase and will be ready for sale in grocery stores by the end of 
2017.22 Moving forward, the FDA has not been able to absolutely 
guarantee that AquAdvantage salmon are safe to eat and severe 
environmental degradation is likely to result from poor review of such a 
product. The new field of GE food products must be approached with 
caution and skepticism. 
This Note seeks to address the issues concerning the FDA’s approval 
of genetically modified salmon for consumption, arguing that the FDA did 
not properly vet AquAdvantage salmon, as well as relied on inappropriate 
criteria in their approval of its market use. Part I provides a brief history 
of AquAdvantage salmon’s introduction to U.S. markets and the legal 
actions taken in response to the FDA ruling. Part II discusses the statutes 
and regulations fundamentally relevant to GE products, as well as a 
critique of the way each regulation was used to approve AquAdvantage. 
Part III offers a comparison to the European Union’s methods of tackling 
GE regulation and details why the EU decided to ban AquAdvantage 
salmon. Part IV offers an analysis of the current issues surrounding the 
production of AquAdvantage salmon and explores the potential 
consequences following the FDA ruling. This Note concludes with a 
suggestion to parallel the U.S. regulatory system to the more succinct and 
rigorous process the European Union relies on to regulate GE animals, a 
system that operates under the precautionary principle. This Note will 
recommend that the FDA adhere to the crucial precautionary principle to 
ensure the effects of a new GE product, such as AquAdvantage, are safe 
for the environment before the effects of an unknown product cause 
irreversible damage. 
I. BACKGROUND: A HISTORY OF GE SALMON AND THE PUBLIC 
RESPONSE 
AquaBounty engineered a fast-growing, genetically engineered 
salmon by combining DNA from three distinct species: Atlantic salmon, 
deep-water ocean eelpout, and Pacific Chinook.23 Together, the three 
                                                     
 21. Complaint for Declaratory and Injunctive Relief, Inst. For Fisheries Res. v. Burwell, No. 
3:16-cv-01574 (N.D. Cal. March 30, 2016) [hereinafter Fisheries A]. The Inst. for Fisheries Resources 
case has several pretrial motions that are cited to in this Note. To ensure clarity, each case has been 
labeled with a letter to distinguish between the various motions. 
 22. AquaBounty Techs., Inc., Quarterly Report (Form 10-Q) (Mar. 31, 2017) https:// 
www.sec.gov/Archives/edgar/data/1603978/000160397817000035/aqb10-q2017x03x31.htm [https:// 
perma.cc/7H5X-ZCY6]. 
 23. Genetically Engineered Salmon: What You Should Know, EARTHJUSTICE (Sept. 1, 2016), 
http://earthjustice.org/features/what-you-should-know-about-ge-salmon?utm_source=crm&utm_ 
content=blurb&curation=newsletter [https://perma.cc/93EG-ARU4] (The scientific names for the 
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species created a salmon that reaches maturity in half the time and is 
significantly larger than its non-GE Atlantic salmon counterpart.24 The GE 
salmon consists of a growth hormone gene from the Chinook salmon to 
shorten the overall growth period and has been designed in a specific way 
that renders the salmon 98.9% sterile.25 
A. The Development of AquAdvantage Salmon 
In 1995, AquaBounty Technologies, Inc. submitted a proposal to the 
FDA, spurring a twenty year review process before ultimately receiving 
the approval last year to go forward with the production of AquAdvantage 
salmon.26 Because AquAdvantage salmon is not a GE animal product 
intended for use in pharmaceuticals,27 it is subject to approval as a New 
Animal Drug Application (NADA).28 NADAs are submitted to the FDA 
and the Center for Veterinary Medicine to be evaluated for safety.29 
Previously under NADA, products such as tick control medication and 
pain medication have been approved for use on dogs.30 No NADA 
approved product has ever gone on to be consumed directly by humans in 
the way AquAdvantage salmon would be. The AquAdvantage salmon is 
the FDA’s first approval of a genetically engineered salmon for 
                                                     
three species used to create AquAdvantage salmon are as follows: Salmo salar, Macrozoarces 
americanus, and Oncorhynchus tshawytscha. The Pacific Chinook salmon and the Atlantic are two 
separate species of salmon.). 
 24. FDA Environmental Assessment, infra note 25, at 1; Jim Kozubek, FDA Decision Will Lead 
to First Ever Genetically-Modified Animal for Consumption, TPM IDEA LAB (Oct. 10, 2011, 2:00 
PM), http://talkingpointsmemo.com/idealab/fda-decision-will-lead-to-first-ever-geneticallymodified-
animal-for-consumption [https://perma.cc/PZY2-EBK9]. 
 25. CTR. FOR VETERINARY MED., U.S. FOOD & DRUG ADMIN., AQUADVANTAGE SALMON 
ENVIRONMENTAL ASSESSMENT 101 (2015), https://www.fda.gov/downloads/AnimalVeterinary/ 
DevelopmentApprovalProcess/GeneticEngineering/GeneticallyEngineeredAnimals/UCM466218.pdf 
[https://perma.cc/DJ7H-HVVS]. 
 26. HAROLD F. UPTON & TADLOCK COWAN, CONG. RES. SERV., R43518, GENETICALLY 
ENGINEERED SALMON (2015). For background, see id. at 8–10. 
 27. Pharmaceuticals are included under the definition of “drug” in the Food, Drug, and Cosmetic 
Act. See 21 U.S.C. § 321(g)(1). 
 28. CTR. FOR VETERINARY MED., U.S. FOOD & DRUG ADMIN., GUIDANCE FOR INDUSTRY: 
REGULATION INTENTIONALLY ALTERED GENOMIC DNA IN ANIMALS 15 (2017) https:// 
www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry
/UCM113903.pdf [https://perma.cc/D8U9-6R4L]. The current draft can be found at 82 Fed. Reg. 
17,844. Originally, Guidance 187 was titled “Guidance for Industry: Regulation of Genetically 
Engineered Animals Containing Heritable Recombinant DNA Constructs” and published in 2009. The 
FDA has since renamed it and republished it to the Federal Register for public comment. 
 29. CTR. FOR VETERINARY MED., U.S. FOOD & DRUG ADMIN. FINDING OF NO SIGNIFICANT 
IMPACT, AQUADVANTAGE SALMON (Nov. 12, 2015), https://www.fda.gov/downloads/Animal 
Veterinary/DevelopmentApprovalProcess/GeneticEngineering/GeneticallyEngineeredAnimals/UCM
466219.pdf [https://perma.cc/9CQM-AXGS]. 
 30. Recent Animal Drug Approvals, U.S. FOOD & DRUG ADMIN. (May 01, 2017), https:// 
www.fda.gov/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/ucm363948.htm [https:// 
perma.cc/4G43-AXP9]. 
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consumption in the United States and the only approved GE animal in the 
world considered safe enough to eat.31 
By 2009, AquaBounty provided the FDA with all of the necessary 
studies and in the following year, the NADA was officially evaluated by 
the agency to determine whether the new drug is safe and effective for its 
intended use.32 On September 3, 2010, the FDA declared AquAdvantage 
salmon safe for human consumption as wild Atlantic salmon.33 The FDA 
released its environmental assessment and official finding that GE salmon 
pose no significant risk to the environment on December 26, 2012, for 
public comment.34 The assessment received more than 400,000 comments 
during the comment period (largely opposing the FDA’s finding) but 
within a few months, reached well over 1.5 million negative comments in 
total.35 The concern expressed in those comments was not incorporated 
into the Final Rule. 
On November 19, 2015, a letter stating the approval for use of 
AquAdvantage salmon was delivered to the CEO of AquaBounty 
Technologies, Inc.36 and the Final Rule was published in the Federal 
Register shortly after.37 
B. Environmental Advocates and Public Opposition 
Two major environmental non-profit organizations are responsible 
for generating public awareness and identifying the problems surrounding 
AquAdvantage salmon: The Center for Food Safety38 and Earthjustice,39 
                                                     
 31. FINDING OF NO SIGNIFICANT IMPACT, supra note 29. 
 32. GUIDANCE FOR INDUSTRY, supra note 28, at 13. Effectiveness of an article intended to alter 
a characteristic of an animal is demonstrated by showing that the genetically engineered animal has 
the claimed altered characteristic. Additionally, the FDA requires the manufacturer to submit studies 
discussing the safety and effectiveness of the new animal drug and what risks it may pose to human 
health and/or environmental health. 
 33. See Andrew Pollack, Modified Salmon is Safe, F.D.A. Says, N.Y. TIMES (Sept. 3, 2010), 
http://www.nytimes.com/2010/09/04/health/policy/04salmon.html. 
 34. Draft Environmental Assessment and Preliminary Finding of No Significant Impact 
Concerning a Genetically Engineered Atlantic Salmon; Availability, 77 Fed. Reg. 76,050 (available 
for public comment Dec. 26, 2012) (codified at 80 Fed. Reg. 73,104). 
 35. Press Release, Earthjustice, Nearly 1.5 Million Objections to Genetically Engineered Salmon 
Filed with FDA (Apr. 25, 2013) http://earthjustice.org/news/press/2013/nearly-1-5-million-
objections-to-genetically-engineered-salmon-filed-with-fda [https://perma.cc/WTK4-FD9F]. 
 36. Bernadette M. Dunham, FDA, Letter to Dr. Ronald Stotish, AquAdvantage Salmon Approval 
Letter and Appendix, NADA 141-454 (Nov. 19, 2015), https://www.fda.gov/ 
AnimalVeterinary/ucm466214.htm [https://perma.cc/7Q4B-PBYN]. 
 37. FDA Final Rule, New Animal Drugs in Genetically Engineered Animals, 80 Fed. Reg. at 
73,104. 
 38. CENTER FOR FOOD SAFETY, http://www.centerforfoodsafety.org/# [https://perma.cc/KAA7-
THYD]. 
 39. EARTHJUSTICE, http://earthjustice.org (last visited May 30, 2017) [https://perma.cc/YATC-
EFD5]. 
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located in Washington, D.C. and San Francisco, respectively. The 
organizations are two of the primary named plaintiffs in the lawsuit filed 
against the FDA, joined by the Center for Biological Diversity, Friends of 
the Earth, and Food and Water Watch.40 Both organizations involved have 
not only brought a legal challenge to the AquAdvantage ruling but have 
actively engaged the public to oppose the rule throughout the entire 
twenty-year review process. To date, over two million people have 
submitted comments in opposition to GE salmon.41 
Critiques directed at the FDA and AquaBounty span far and wide, 
from environmental advocates claiming that “[the] federal government 
agencies are ill-equipped to handle genetically engineered animals”42 to 
influential retailers announcing their refusal to stock the GE salmon out of 
concern for food safety and environmental impact to wild salmon runs.43 
The national campaign launched by the Center for Biological Diversity 
helped yield a large number of the public comments and signatures posted 
to the Federal Register following the FDA’s decision.44 The Center for 
Food Safety created a platform for grocers, restaurateurs, and other food 
suppliers to pledge against buying, selling, or serving genetically 
engineered salmon in their establishments.45 Earthjustice continues to 
oppose the ruling in court while also educating consumers about the food 
safety concerns, the environmental impact, and the labeling issues 
surrounding GE salmon.46 In addition to the millions of public comments 
received opposing the issue, several news sources, as well as politicians 
                                                     
 40. See Fisheries A, supra note 21. 
 41. See Genetically Engineered Salmon, supra note 23. 
 42. Brady Dennis, The FDA Just Approved the Nation’s First Genetically Engineered Animal: 
A Salmon that Grows Twice as Fast, WASH. POST (Nov. 19, 2015) (quoting Dana Perls, food and 
technology campaigner at Friends of the Earth), https://www.washingtonpost.com/news/to-your-
health/wp/2015/11/19/the-fda-just-approved-the-nations-first-genetically-engineered-animal-a-
salmon-that-grows-twice-as-fast/?utm_term=.3ac90b4ffd70 [https://perma.cc/5DJU-J45F].  
 43. Madelyn Kearns, Here are the Retailers Who Won’t Sell AquaBounty’s GM Salmon, 
SEAFOOD SOURCE (Nov. 23, 2015), http://www.seafoodsource.com/news/foodservice-retail/here-are-
the-retailers-who-won-t-sell-aquabounty-s-gm-salmon [https://perma.cc/4KEF-6ZGJ]. 
 44. See FDA Final Rule, New Animal Drugs in Genetically Engineered Animals, 80 Fed. Reg. 
at 73,104 
 45. Press Release, Ctr. for Food Safety, Costco Will Not Sell GMO Salmon (Nov. 24, 2015) 
http://www.centerforfoodsafety.org/press-releases/4141/costco-will-not-sell-gmo-salmon [https:// 
perma.cc/3ATP-TK3Z]; see also Join the Campaign to Stop GE Fish, CTR. FOOD SAFETY, 
http://www.centerforfoodsafety.org/issues/309/ge-fish/join-the-campaign-to-stop-ge-fish [https:// 
perma.cc/ES5E-VG9K]. 
 46. In July 2013, the New York Times conducted a poll of its readers asking their opinion on 
whether GE food should be labeled in the grocery store. An overwhelming 93% of readers stated foods 
should be identified and 75% expressed concern with genetically engineered foods. See Allison 
Kopicki, Strong Support for Labeling Modified Foods, N.Y. TIMES (July 27, 2013) 
http://www.nytimes.com/2013/07/28/science/strong-support-for-labeling-modified-foods.html. See 
generally Genetically Engineered Salmon, supra note 23. 
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on either side of the aisle, added their support for the environmental 
advocates challenging the FDA.47 Senator Lisa Murkowski spoke out in 
response to the FDA’s announcement of the final rule, stating that she was 
“livid at the FDA’s announcement to approve genetically engineered 
‘salmon’—what seems to be more science experiment than fish or food.”48 
C. Salmon’s Day in Court 
The Center for Food Safety, Earthjustice, and other environmental 
groups collectively filed a lawsuit challenging the FDA’s approval of 
AquAdvantage salmon. They alleged that the Food, Drug, and Cosmetic 
Act (FDCA) does not grant authority to the FDA to regulate GE animals.49 
The plaintiffs challenged the validity of the 2009 Guidance for Industry 
declaration, and claimed that it was inadequate on the grounds that “it fails 
to consider environmental risks.”50 The claim also included a criticism of 
the FDA for failing to conduct an environmental impact statement as 
required by the National Environmental Policy Act (NEPA) to consider 
the “risk that man-made salmon could escape from facilities, interbreed 
with wild salmon, and compete with other animals for food and space.”51 
The injunction against the FDA and the Fish and Wildlife Service was 
filed on March 30, 2016 in the United States District Court for the 
Northern District of California.52 
Later, on August 30, 2016, the court granted the respondent’s motion 
to dismiss on the grounds that a challenge may not be brought against 
EPA’s “no effect” determination to endangered salmon because it was not 
a final agency action.53 The court reasoned that the responses offered from 
the government were not final action because they were “purely advisory 
and lacked direct and appreciable legal consequences.”54 For the plaintiffs 
to bring a claim under the Administrative Procedure Act, the action must 
be a final agency action.55 The court went on to say that the “no effect” 
                                                     
 47. See supra text accompanying note 46; see also William Yardley, Genetically Engineered 
Salmon Is Fit For Dinner, FDA Says in First Decision of its Kind, L.A. TIMES (Nov. 19, 2015), 
http://www.latimes.com/nation/la-na-sej-gmo-salmon-20151120-story.html [https://perma.cc/9AFC-
NBK3]. 
 48. Yardley, supra note 47 (quoting U.S. Senator Lisa Murkowski). 
 49. See Fisheries A, supra note 21. The lawsuit was filed under the Administrative Procedure 
Act, which grants a right of judicial review to a person suffering legal wrong because of agency action, 
or adversely affected or aggrieved by agency action. 5 U.S.C. § 702 (1976). 
 50. Fisheries A, supra note 21, at 11, 12. 
 51. Id. 
 52. Id. 
 53. Order for Motion to Dismiss, Inst. for Fisheries Res. v. Burwell, No. 16-cv-01574-VC (N.D. 
Cal. Aug. 30, 2016) [hereinafter Fisheries B]. 
 54. Id. at 2. 
 55. 5 U.S.C. § 704. See generally Fisheries B, supra note 53. 
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determination may be argued as an arbitrary and capricious value by the 
plaintiffs at a future hearing, but that the claim was not valid in that 
proceeding.56 
Litigation has continued with U.S. District Court Judge Chhabria 
delivering the most recent judgment on January 10, 2017.57 The court 
granted the plaintiff’s motion to compel the government to produce 
materials and documents related to the case, claiming that the 
administrative record was incomplete.58 The judge concluded that no 
privilege applied to the materials and documents; therefore, the 
government must release all documents related to the agency’s approval 
of AquAdvantage salmon.59 The significance of the decision is twofold—
the judicial system has signaled to agencies that they expect transparency 
of their approval process; and the ruling opens the door for further 
enforcement that proper evaluation of potential risks is completed before 
approving future GE products. 
II. REGULATORY FRAMEWORK 
Historically, Congress never considered the regulation of food 
genetically engineered in labs; therefore, no designation was made for 
which agency would hold proper jurisdiction to regulate GE products. 
When engineered corn and other major crops were increasingly used, the 
United States entered the era of biotechnology, and policymakers drafted 
regulations to cover this scope of new foods. 
A. Regulatory Authority for the FDA 
Biotechnology and the engineering of genetically engineered foods 
became popular in the 1980s; this pressured the White House to create the 
Coordinated Framework for Regulation of Biotechnology in 1986.60 The 
Coordinated Framework identified three agencies—the U.S. Department 
of Agriculture, the Environmental Protection Agency, and the U.S. Food 
and Drug Administration—to share the regulatory responsibilities of 
biotechnology; the FDA was charged with evaluating food safety issues 
for all genetically engineered products.61 The legislation most importantly 
                                                     
 56. Fisheries B, supra note 53, at 3. 
 57. Order to Compel Completion of Administrative Record Inst. For Fisheries Res. v. Burwell, 
No. 16-cv-01574-VC (N.D. Cal. Jan. 10, 2017) [hereinafter Fisheries C]. 
 58. Id. A complete administrative record includes all documents and materials directly or 
indirectly considered by agency decision-makers. 
 59. Id. 
 60. Coordinated Framework for Regulation of Biotechnology, 51 Fed. Reg. at 23, 302 (June 26, 
1986). 
 61. For the purposes of this Note, only the role of the FDA will be discussed in detail because 
the roles assigned to the Dept. of Agriculture and the EPA do not include GE animals. Id. at 23, 303. 
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states that GE products are not inherently riskier than their natural analogs 
and, therefore, GE products can be adequately regulated by the pre-
existing statutory and regulatory structure.62 
The category of genetically engineered plants and animals was not 
included in the original text outlining the scope of products subject to FDA 
regulation. The term GE is applied to any plant, crop, or animal once their 
genetic material has been modified using rDNA techniques to produce a 
new trait, such as reaching a larger adult size or a faster growing rate.63 
When GE crops began to appear on the market, the FDA relied on an 
inventive interpretation of the FDCA to claim regulatory authority over 
the new plant and crop products. Congress enacted the FDCA in 1938, 
granting the FDA authority to oversee the safety of food, drugs, and 
cosmetics.64 Specifically, the FDA relied on language in Section 409 to 
regulate GE plants; the agency interpreted “food additives” to encompass 
genetic material as part of the definition.65 The provision defines food 
additives as “any substance intended for the use in food, that may 
reasonably be expected to become a component of food, or that may 
otherwise affect the characteristics of food.”66 
Section 409 goes on to say that FDA approval is not required if the 
food additive in question is “generally recognized among experts to be 
safe under the conditions of its intended use.”67 In 1992, the FDA made its 
position to industry regarding GE foods blatantly clear: the agency would 
presume GE plants and crops to be “generally recognized as safe,” 
releasing manufacturers from waiting for the official go-ahead from the 
FDA before producing their GE products.68 This places an enormous 
amount of trust in the industries to produce safe food that meet FDA 
standards, instead of in the FDA to evaluate the food’s safety. To bridge 
the regulatory gap between GE plants and GE animals, the FDA issued its 
“Guidance for Industry 187: Regulation of Intentionally Altered Genomic 
DNA in Animals” to assert primary authority over GE animals in the 
United States based on logic utilized previously for GE plants and crops.69 
The broad interpretation of terms for GE plants within the FCDA 
opened the door for the FDA to extend its authority regulating GE animals, 
specifically under the “new animal drug” provision. A “new animal drug” 
                                                     
 62. Id. at 23, 306. 
 63. See GUIDANCE FOR INDUSTRY, supra note 28. 
 64. Food, Drug, and Cosmetic Act, 21 U.S.C. § 301 (1938). 
 65. Id. § 393 (1938). 
 66. Id. § 393(s). 
 67. Id. 
 68. Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed. Reg. 22,984, 22,990 
(May 29, 1992). 
 69. See GUIDANCE FOR INDUSTRY, supra note 28. 
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is defined as “any drug intended for use in animals other than man;”70 the 
term “drugs” is defined in the Act as “articles (other than food) intended 
to affect the structure or any function of the body of man or other 
animals.”71 These definitions, along with the classification of GE products, 
provide the language the FDA uses to include GE animals within the scope 
of its regulatory authority.72 Specifically, the rDNA techniques used on a 
GE animal product to alter the structure or function of the natural animal, 
regardless of the intended use of products that may result from the 
production of the GE animal, satisfies the definition of “drug;”73 analogous 
to the application implored by the FDA in order to regulate GE plants, the 
agency stretched the regulation’s language to work for industry 
applications. 
A new animal drug will not be considered safe by the FDA until it 
has approved a NADA, which will determine whether the new animal drug 
is safe and effective for its intended use.74 The FDCA determines that the 
safety of a new animal drug is only within “reference to the health of man 
or animal” and “environmental effects that directly or indirectly affect the 
health of humans or animals.”75 AquaBounty received approval of its 
NADA along with an official notice approving AquAdvantage in 
November 2015.76 The standard of review does not address negative 
implications to the environment unless a direct risk to man exists, nor does 
it provide opportunity for the public to comment on the NADA or even be 
aware of its filing.77 When the district court issued a ruling to produce the 
materials the FDA used in its review process, it was intending to address 
this exact concern.78 
When the FDA claimed regulatory authority over AquAdvantage 
salmon through the new animal drug definition, the agency effectively laid 
claim on any subsequent GE animal applications in the future. The critique 
of the FDA’s conduct is intended to expose the negative details of the 
current GE approval process, as well as highlight the alarming issue of the 
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FDA setting poor precedent for reviewing future GE animal products. 
First, the FDA acted quickly to regulate GE animals and, in doing so, was 
able to create its own set of standards with the goal of approving 
AquAdvantage. That set of standards will translate as the accepted policy 
for GE animal applications, creating a greater entanglement of problems 
in the future if the fundamental issues are not addressed. Second, when 
presented with a first of its kind GE application, the proper protocol for 
the FDA would be to table the application and craft the appropriate 
regulatory scheme, including consultation requirements to the appropriate 
agencies, before working through the application. Instead, the FDA chose 
to fashion its regulation around an application and a specific set of 
circumstances with very little thought to its effect in the future. The FDA 
ultimately is risking our natural food system, a variety of crucial 
environments, and human health. 
B. The National Environmental Policy Act 
In 1970, Congress enacted NEPA to encourage productive and 
enjoyable harmony between humans and the environment, to promote 
efforts that prevent or eliminate damage to the environment and biosphere, 
and to enrich the understanding of the ecological systems and natural 
resources important to the nation.79 
Under NEPA requirements, the FDA is obligated to coordinate with 
any agency whose jurisdiction might be affected by the approval of a 
NADA and ultimately the GE animal,80 unless the FDA included NEPA 
requirements in its initial review.81 There are four general principles that 
the FDA’s review would need to include: (1) whether the genetically 
engineered animal poses any threats to humans, animals, or the 
environment; (2) whether, in the event of a release, the genetically 
engineered animal poses any more environmental threat than the non-
genetically engineered equivalent; (3) whether the disposal of genetically 
engineered animals poses any threats to humans, animals, or the 
environment; and (4) whether any other safety issues remain unaddressed 
by the sponsor.82 
Under NEPA, a new animal drug applicant is then required to submit 
an Environmental Assessment (EA) to the agency; the agency will rely on 
the assessment to determine how an approved product would impact the 
                                                     
 79. 42 U.S.C. § 4321 (1970). 
 80. 21 C.F.R. § 25.15(b) (2015). 
 81. GUIDANCE FOR INDUSTRY, supra note 28, at 7. 
 82. Id. at 8. 
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environment.83 An EA can result in two major findings: either the product 
is categorically excluded, which would be preferred by the FDA as it ends 
their commitment to NEPA84 or a possibility of significant risk of adverse 
environmental impact, which would require the FDA to submit to a more 
rigorous review process and complete an environmental impact 
statement.85 
The EA for AquAdvantage salmon was issued, ending the 
requirement for ongoing consultation with NEPA. The agency reached its 
conclusion that there was no significant impact based on evidence that 
failed to address the many problems with AquAdvantage salmon. The 
FDA originally classified AquAdvantage salmon as having a “may effect” 
determination and adjusted the status to “no effect” upon receiving an 
informal suggestion from Fish & Wildlife to do so.86 Aside from this 
suggestion, it is unclear how the “no effect” determination was reached; 
Judge Chhabria expressed his confusion over the determination by 
hypothesizing that the agency could have been looking for a way to avoid 
further obligation to complete the consultation with the FDA.87 Until 
recently, the FDA has adamantly refused to provide details of the 
AquAdvantage approval process and its reasoning for allowing the project 
to move forward.88 The recent order to release materials and documents 
related to the approval of AquAdvantage salmon will begin to provide 
insight on why the agency acted as it did, and will further provide answers 
to the questions surrounding the no effect determination.89 Those materials 
and documents become crucial to understanding the faults in the current 
approval process and play a significant role in successful litigation. 
Furthermore, the impending agency budget cuts will hinder its ability 
to produce scientific reports and necessary environmental assessments. If 
agency funding is drastically reduced, as proposed by the current 
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presidential administration,90 the United States will continue to approve 
threatening products and move blindly into the consequences from those 
decisions. 
C. Endangered Species Act 
Since its enactment in 1973, the ESA has been the cornerstone of 
conservation efforts to preserve animals, plants, and ecosystems in the 
United States.91 The ESA’s primary objectives are to prevent species 
extinction and facilitate the recovery of listed species, while striving to 
maintain healthy ecosystems and a vast network of biological diversity.92 
The U.S. Fish and Wildlife Service and the National Marine 
Fisheries Service (together, the “Services”) oversee and manage the listed 
plants or animals and marine species, respectively.93 When a species is 
considered for listing, the Services use two categories, threatened or 
endangered, to make its final determination for each particular species.94 
The ESA defines an endangered species as one that is in danger of 
extinction throughout all or a significant portion of its habitat range, while 
a threatened species is one that is likely to become endangered in the 
foreseeable future.95 Once federal protection has been extended to a 
species, the Services will designate critical habitat boundaries, a recovery 
plan, and any other necessary protections that will aide in the species’ 
revival.96 To date, the ESA has succeeded in restoring a remarkable 99% 
of the species listed, making it one of the most effective pieces of 
environmental legislation in history.97 
As stated in the introduction of this Note, the Atlantic salmon was 
first listed as endangered on November 17, 2000.98 The Services identified 
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the Gulf of Maine as critical habitat for salmon due to its quality spawning 
grounds.99 Coincidentally, the designated habitat overlaps with the 
location of AquaBounty’s production facilities in southeastern Canada. 
The location has prompted a majority of the criticism directed at 
AquAdvantage salmon because it poses adverse risk to a critically 
endangered species; the significance of the production location to the 
endangered salmon population will be discussed in detail in section IV. 
Section 7 of the ESA designates the responsibility to consult with 
either FWS or NOAA fisheries whenever a federal agency is authorizing 
a rule that may impose harm to endangered or threatened species.100 This 
provision is crucial to protecting sensitive species from any future activity 
that could adversely affect individuals or their designated critical habitat. 
The principal takeaway from this section of the ESA is the conservation 
provision which requires the agency, with the help of the Services, to 
develop a biological opinion and plan that will preserve listed species from 
harmful conduct.101 Ultimately, the agency is charged with the 
responsibility to insure that any action authorized, funded, or carried out 
is not likely to jeopardize the continued existence of any endangered 
species or threatened species, or result in the destruction or adverse 
modification of habitat of such species.102 The biological opinion is meant 
to act as guidance for rule makers to conform agency action to the 
parameters of endangered species. 
The take prohibition in Section 9 outlines one of the enforcement 
clauses provided by the ESA.103 Take is defined as “to harass, harm, 
pursue, hunt, shoot, wound, kill, trap, capture, or collect, or attempt to 
engage in any such conduct” to any individual or population of an 
endangered or threatened species.104 Other interpretations have expanded 
this definition to include not only direct harm to the species, but also 
indirect harm by impairing the habitat in a way that may cause death or 
injury by disrupting feeding, breeding, or essential behavior patterns.105 
On several occasions, the Supreme Court has upheld the Services 
determination of harm106 stating, “the ESA’s prohibition against harming 
a species included habitat destruction severe enough to adversely affect a 
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listed species as a whole” and, as a result, industry challenges to this 
definition have failed.107 
If AquaBounty follows through with their production plans, their 
actions most certainly will constitute a takings claim with respect to the 
harm caused to the endangered Atlantic salmon populations in Maine. 
Once a species has been listed on the ESA, the protections in place do not 
allow for any harm to be inflicted upon the species; evidence of disrupted 
breeding patterns or death to one individual will trigger the statute’s 
safeguards and immediately result in a violation. The failure to account for 
the outward harm to endangered salmon and their designated habitat is a 
major oversight and will most certainly result in lawsuits once harm is 
inflicted. The Atlantic salmon populations face immediate danger if 
AquaBounty’s facilities on Prince Edward Island, Canada are built;108 if 
successful, AquaBounty may eventually build facilities in the Pacific 
Northwest, placing the four populations of endangered salmon at risk. 
III. ACROSS THE STOCK POND: THE EU REGULATORY STRUCTURE 
In 2001, the European Council adopted Directive 2001/18/EC on the 
Deliberate Release of Genetically Modified Organisms.109 Pursuant to 
Article IV, applicants are required to apply and submit an environmental 
risk assessment in order to gain the Council’s approval for use of GE 
products, as well as submit an application to each Member State in which 
they wish to market genetically modified products.110 The Member States 
will then designate competent authorities to examine notifications of GE 
products, and establish inspection measures.111 Applicants must also be 
able to ensure traceability of marketed products. Subsequent to the 
Directive Order, debates arose all over Europe regarding GE corn and soy 
bean products, which were largely focused on labeling requirements and 
fighting the negative public opinion regarding GE products.112 Directive 
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2001/18/EC further requires consultation with its scientific risk agency in 
cases where a competent authority raises objections regarding the risks of 
the GE product to human health or the environment, and in which the 
assessment report of the authority that received the notification indicates 
that the GE product should not be released onto the market.113 
The European Food Safety Authority (EFSA) is an agency in the EU 
that provides independent scientific advice and comments on existing and 
emerging risks to food safety. The EFSA published guidance on the 
environmental risk assessment of GE animals, which provided 
information for applicants and risk assessors on how to conduct an ERA 
of living GE animals placed on the EU market.114 The document outlines 
three primary aspects that should be included for a thorough risk 
assessment: (1) applicants must complete a six-step assessment procedure 
that will identify potential hazards and the extent of human, animal, and 
environmental exposure to them, consistent with EU legislation; (2) 
applicants must address seven areas of potential risk for GE animals; and 
(3) applicants must consider viable alternatives, including cross-cutting 
considerations, surrogate animals, and recommendations specific to the 
environment into which GE animals are likely to be released.115 This 
process ultimately includes a comment period and consideration of the 
societal and economic aspects of approving a GE animal in the EU; 
however, the EFSA solely examines the risk factor of the decision.116 
The fundamental theme throughout the EU’s regulatory system is the 
precautionary principle, an approach that guarantees a high standard of 
environmental protection through preventative decision-making in the 
case that risks are reasonably suspected.117 Encouragement for nations to 
adopt the precautionary approach is well established in the UN Global 
Compact. Rio Principle 7 specifically addresses the importance of 
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implementing preventative measures over remedial ones.118 The concept 
of the precautionary principle is easily distinguished from what is known 
as the principle of prevention because of the effort to apply caution to 
scientific information that is either incomplete or inconclusive.119 In 
contrast, the principle of prevention allows action first and reaction only 
when something goes awry; currently, the United States operates under the 
latter approach.120 
The first formal inclusion of the principle was published in 2000 in 
the European Commission’s documents, establishing the use of the 
precautionary principle: “[W]here a full risk assessment is not possible, 
measures should be based on the precautionary principle” and only applied 
after the maximum possible scientific assessment of the risks.121 Within 
the Communication are the guidelines for applying the principle to 
regulation, stating that measures based on the precautionary principle 
should be 
[p]roportional to the chosen level of protection, non-discriminatory 
in their application, consistent with similar measures already taken, 
based on an examination of the potential benefits and costs of action 
or lack of action (including, where appropriate and feasible, an 
economic cost/benefit analysis), subject to review in the light of new 
scientific data, and capable of assigning responsibility for producing 
the scientific evidence necessary for a more comprehensive risk 
assessment.122 
In the case of GE products, the EU and its environmental agencies 
have been able to gain a wider breadth of knowledge about how the 
proposed animal or plant product will impact human health and the 
environment, as well as provide a greater level of assurance to the EU 
population that food is held to a high safety standard, despite its new 
genetic makeup. 
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The United States and Canada remain the only two countries to 
approve applications for AquAdvantage salmon.123 The former Chair of 
the European Food Safety Authority GMO Panel spoke on the possibility 
of AquaBounty filing for approval in the EU market following the FDA 
approval for U.S. markets in 2015, expressing great concern for the notion 
and holding the opinion that the GE salmon had not had the rigorous 
review it ought to have been subjected to: 
My view is that if an application were to be made for such GM 
salmon to be released in Europe, then the risk assessment would 
require considerably more data to demonstrate the efficacy of the 
induced sterility in these GM salmon than were required by the Food 
and Drug Administration.124 
Health Canada, the Canadian agency equivalent to the FDA, 
approved AquAdvantage salmon on May 19, 2016.125 In defending its 
decision, the agency stated that the GE salmon is “identical to other farmed 
salmon” and assured Canadians opposing the approval that their scientists 
conducted a thorough analysis of all potential dangers.126 Similar to the 
court proceedings currently underway in the U.S., several Canadian 
environmental groups attempted to block AquaBounty, Inc., but were 
unsuccessful in their efforts.127 These groups echoed the same concerns 
that Earthjustice and the Center voiced in regards to escape and 
endangerment to the endangered Atlantic salmon populations.128 As far as 
the precautionary principle is concerned, Health Canada has faced legal 
challenges to its past decisions on the basis that the agency has ignored its 
commitment to utilize the precautionary approach.129 Petitioners to the 
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Auditor General of Canada allege that Health Canada clearly abandoned 
its promise to adopt the precautionary principle in many recent decisions, 
including the decision to approve AquaBounty’s GE salmon.130 
IV. A NEW APPROACH TO THE REGULATION OF GE ANIMALS 
The approval process the FDA relies on to regulate GE products has 
led us to a market that includes AquAdvantage salmon and opened the 
door for any number of GE animal products to enter the market in the 
future. As many environmental groups and health advocates have argued, 
the regulatory system needs to (1) consist of a more comprehensive 
consultation with the appropriate environmental agencies; (2) include a 
more robust use of the best available science that analyzes adverse impacts 
a product may cause; and (3) take a conservative approach when ruling on 
a proposed GE animal. Two leading biologists published a comment on 
the Federal Register, stating that they had “found major scientific 
inadequacies in this EA that set an unacceptably low bar for the scientific 
basis of future EA or EIS documents” and further expressing concern for 
the future approval of GE animals with “more ecologically disruptive 
traits.”131 This Note proposes a change to the FDA approval process that 
aligns with the EFSA requirements and includes a strategy that U.S. 
environmental legislation is already familiar with. 
A. The Precautionary Principle 
As discussed above, the core of the EU regulatory framework for 
environmental matters is the precautionary principle, a concept that aims 
to prevent harm before it occurs; prevention is key to enacting effective 
environmental legislation considering most of the injury sustained is 
permanent and not easily remedied with money. In contrast to the EU 
framework, the precautionary principle appears only a handful of times in 
U.S. regulation. For example, the FDCA bans the use of any food additive 
if tests reveal that it caused cancer in either laboratory animals or humans 
on the grounds that such chemicals could cause irreversible harm to 
consumers.132 
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Successively, the EPA uses the principle in the Federal Insecticide, 
Fungicide, and Rodenticide Act (FIFRA) to restrict the sale, distribution, 
or use of any pesticide unless granted express approval prior to entering 
the market.133 Before the EPA may authorize a pesticide, the claimant must 
show that using the pesticide will not result in unreasonable, adverse 
effects on the environment.134 In 1996, the Food Quality Protection Act 
(FQPA) was amended to require the re-examination of pesticides under its 
new risk-based registration, specifically to identify potential impacts 
resulting from the use of pesticides.135 The FQPA marks the accepted use 
of the precautionary approach for risk management and the reliance on 
best available scientific data to approve use only if “there is a reasonable 
certainty that no harm will result,” adding a great deal of protection to the 
environment.136 Congress enacted the above policies to shift the burden of 
proof to industry; Congress did so to require industry to prove the safety 
of their products in order to prioritize a healthy environment and to slow 
the degrading effects to the global environment. By only reacting to 
environmental disasters instead of preventing injury, we have effectively 
expedited the negative implications to our environment. 
B. A Case Study 
When utilized, the precautionary principle is one of the most robust 
clauses in environmental legislation; it justly imposes a duty upon the 
industry and individual manufacturer to prove its product poses no 
significant threat or risk of safety to consumers and the environment. A 
precautionary approach toward risk regulation was enforced through 
several modern-era judicial decisions. Ethyl Corp. v. EPA marks the 
cornerstone interpretation of how the precautionary principle has an 
impact on industry; the court in Ethyl Corp. ruled that preventing harm is 
within the agency’s discretion when significant risk exists.137 As upheld 
consistently by federal courts, “where existing methodology or research in 
a new area of regulation is deficient, the agency necessarily enjoys broad 
discretion to attempt to formulate a solution to the best of its ability on the 
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basis of available information.”138 The ruling in Ethyl Corp. certainly 
extends to the situation arising around AquAdvantage salmon; GE animals 
are a previously unregulated area of law and contradicting science 
suggests that serious negative side effects exist—calling on the agency to 
take a precautionary approach.139 To rule on removing lead from gasoline, 
the court reached its conclusion by weighing public interest against the 
gasoline company’s interests, effectively lowering the proof of harm the 
EPA was required to demonstrate.140 Ethyl Corp. established the need to 
allow environmental agencies to act preventatively while regulating 
industry, stating, “[a]waiting certainty will often allow for only reactive, 
not preventative, regulation.”141 Another court followed the example set 
out by Ethyl Corp. and held in Sierra Club v. Sigler that if “an agency is 
evaluating significant adverse effects on the human environment in an 
environmental impact statement and there are gaps in relevant information 
or scientific uncertainty, the agency shall always make clear that such 
information is lacking or that uncertainty exists.”142 Sigler gave way to the 
interpretation that the environmental impact provision of NEPA also 
required a worst-case analysis on the grounds that it was needed to assist 
decision-making when scientific uncertainty exists.143 
Where there are threats of irreversible damage, a rule based on a lack 
of full scientific certainty should not be used as justification for postponing 
cost-effective measures, thus accelerating further environmental and 
public health degradation. In the case of AquAdvantage salmon, the full 
review of the product was not completed to the extent required by 
environmental agencies.144 This is in part due to the fact that the FDA is 
simply unfit to rule on the safety of animals; their interpretation that 
AquAdvantage salmon qualified as a new animal drug was inappropriate, 
seeing as this specimen is a new species entirely. Moving forward, the 
FDA must either adopt a system that better analyzes and studies an 
applicant’s product—akin to the precautionary principle—or repeal its 
regulatory authority over GE animal species. As is, the regulatory structure 
will lead to devastating effects to our ecosystems, our citizens’ health, and 
our natural resources. 
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C. Remaining Questions 
While AquaBounty has addressed some of the major criticisms and 
taken steps to prevent escapes into wild salmon runs, a number of 
unanswered questions remain as the project moves forward. First and 
foremost, AquaBounty has failed to consider that salmon escapes are still 
a significant possibility.145 If GE salmon escape into wild streams and 
rivers, there is no recapture plan in place by AquaBounty and it is nearly 
impossible to recover those individuals.146 The intermixing of the two 
distinct salmon species will create competition for resources that the larger 
GE salmon will easily win; the FDA believes that this is not an unlikely 
situation.147 While the two facilities of production are currently in Panama 
and southeastern Canada,148 AquaBounty has spoken on several occasions 
of its intent to open multiple facilities in the United States. On June 13, 
2017, AquaBounty acquired its first U.S. fish farm in Albany, Indiana; the 
facility will support a capacity of 1,200 metric tons of salmon per year.149 
The company expects its first harvest from the Indiana site to be ready by 
late 2019.150 The company is moving quickly to establish its presence in 
U.S. grocery stores,151 and it is inevitable that GE salmon will come closer 
to our vulnerable wild populations if production continues to proceed. 
Regardless, AquaBounty has already incurred environmental safety 
violations with only two land-based facilities in operation.152 In 2014, 
                                                     
 145. See generally Rosamond Naylor et al., Fugitive Salmon: Assessing the Risks of Escaped 
Fish from Net-Pen Aquaculture, 55 BIOSCIENCE 427–37 (May 1, 2005). 
 146. Brettny Hardy, What Will Happen When Genetically Engineered Salmon Escape Into the 
Wild?, EARTHJUSTICE (Apr. 08, 2016), http://earthjustice.org/blog/2016-april/what-will-happen-
when-genetically-engineered-salmon-escape-into-the-wild [https://perma.cc/3W65-T9PK]. 
 147. FDA Final Rule, New Animal Drugs in Genetically Engineered Animals, 80 Fed. Reg. at 
73,104. See generally Naylor, supra note 145. 
 148. Questions and Answers on FDA’s Approval of AquAdvantage Salmon, U.S. FOOD & DRUG 
ADMIN. (Dec. 21, 2015), http://www.fda.gov/AnimalVeterinary/DevelopmentApprovalProcess/ 
GeneticEngineering/GeneticallyEngineeredAnimals/ucm473237.htm [https://perma.cc/9W5J-
PTQS]. 
 149. Press Release, AquaBounty, Inc., AquaBounty Acquires Fish Farming Facility in Indiana 
(June 13, 2017), http://phx.corporate-ir.net/phoenix.zhtml?c=197553&p=irol-newsArticle&ID= 
2280501 [https://perma.cc/4HAN-HCR2]. AquaBounty purchased facilities from Bell Fish Company 
for $14 million dollars. 
 150. Id. 
151 As of August 4, 2017, Canadian grocery stores began selling AquAdvantage salmon without 
labeling or otherwise distinguishing the product from non-GE salmon. Jenna Gallegos, GMO Salmon 
Caught in U.S. Regulatory Net, but Canadians have eaten 5 tons, WASH. POST (Aug. 4, 2017) https:/ 
/www.washingtonpost.com/news/speaking-of-science/wp/2017/08/04/gmo-salmon-caught-in-u-s-
regulatory-net-but-canadians-have-eaten-5-tons/. 
 152. AquaBounty Fined for Repeated Environmental Violations on Genetically Engineered 
Salmon, FOOD & WATER WATCH (Oct. 28, 2014), http://www.foodandwaterwatch.org/news/ 
aquabounty-fined-repeated-environmental-violations-genetically-engineered-salmon [https:// 
perma.cc/95CY-GW39]. Original document available, in Spanish, at: http:// 
334 Seattle University Law Review [Vol. 41:1 
Panamanian officials fined the company for water discharge violations and 
failing to address a storm-related incident that led to lost salmon.153 
Wenonah Hauter, the Executive Director for Food and Water Watch, made 
the following statement in the organization’s release of the safety report, 
“FDA has always assured the public that it is checking, monitoring and 
regulating AquaBounty’s production platform to ensure the company can 
mitigate the well-documented environmental impacts of escaped GE 
salmon . . . AquaBounty is unwilling or unable to follow basic rules and 
regulations, and FDA is unable to enforce them.”154 Furthermore, the FDA 
expressly stated in its Finding of No Significant Impact report that it did 
not consider the impacts that either facility would have on the surrounding 
environment and only granted the application because production would 
not occur on U.S. soil.155 
Second, while the AquAdvantage salmon are treated to create sterile 
individuals, the methods are only about 97% effective.156 When the 
remaining 3–5% is stacked up to the hundreds of thousands of eggs 
AquaBounty plans to produce, thousands of fish will be left fertile; this 
failure to render 100% of its stock sterile creates a greater risk to an already 
fragile wild salmon population.157 Finally, whether the claim that GE 
salmon is actually healthier for human consumption than wild salmon is 
split by contradicting research; biologists maintain the position that there 
is little research showing that long-term consumption of fish with added 
growth hormones is completely safe for humans, while AquaBounty 
insists the AquAdvantage salmon is a healthier choice. Over the last few 
decades, reports ranging from the reproductive risks of chemicals in 
sunscreens to the carcinogens in pesticides applied to crops have been 
presented to the public; this demonstrates the necessary research of a 
product to ensure safety before use is routinely omitted from legislative 
requirements. In these cases, opposition from similar stakeholders had 
been presented and ignored. The “wait and see approach” the FDA is 
inclined to utilize for AquAdvantage salmon is not only unsuitable for 
food but unsubstantiated by the record of past products assumed to be fine. 
The threshold question for many scientists, consumers, and 
environmental advocates opposing GE salmon asks whether the FDA 
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ruling has established a dangerous precedent for our food system and what 
will follow next. By simply following the manufacturers’ claims of 
greener methods and sustainable farming, we are buying into a science-
driven food structure and allowing labs to create our nourishment. 
Submitting to AquaBounty puts into question all other sources of protein 
consumed in the US; will we now become accustomed to GE cows and 
farms stocked with chickens three times their normal size? 
Pursuant to the ESA and the take prohibition in Section 9, any species 
of salmon listed under the ESA may not be exposed to foreseeable risks; 
any caused harm is a direct violation of the ESA.158 In the immediate 
future, Atlantic salmon are at risk of harm if the AquAdvantage salmon 
raised near the Gulf of Maine escape into the bordering designated critical 
habitat.159 Assuming AquaBounty will follow through with its plan to 
build additional production facilities across the U.S., beginning in Indiana, 
what is to say the four salmon species of the Puget Sound will not soon 
experience the pressures of AquAdvantage salmon? Considering the 
millions of consumers and retailers that are vocal about their opposition to 
GE salmon, will this refusal to buy or sell anything but wild-caught salmon 
add extra strains to the wavering wild salmon runs? The GE market poses 
many direct and indirect effects to salmon populations that further put into 
question the survival of the five endangered species in the U.S. 
CONCLUSION 
The salmon case study is a disturbing example of the key weakness 
of the FDA’s approach but also serves as a great example of the strengths 
of the precautionary approach. Public interest and the environment would 
be better served by a policy shift and the granting of jurisdictional 
authority to a more qualified agency, with the expertise to determine safety 
of GE animal products, than the FDA. The precautionary principle is not 
a novel idea to U.S. legislators; by adhering to the millions of people 
opposing GE salmon and enacting the approach that ensures all 
foreseeable and reasonable risks have been addressed, we are more likely 
to have a healthy environment independent of engineered food sources. 
The purpose of environmental law is to protect natural resources 
even when uncertainty of the long-term effects exists. The lasting 
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consequences of losing species, damaging habitat, and degrading human 
health all grossly outweigh the benefits of cheaper production today. 
AquaBounty does not present a solution to address the underlying problem 
of species extinction caused by unsustainable fishing methods and 
overfishing. The efforts being made to skirt around these issues ought to 
instead be spent preserving the natural salmon resource, while still in 
existence, and in doing so tackle the root of the problem. What needs to 
happen now goes beyond bigger and faster-growing fish. The 
AquAdvantage salmon case becomes another important cause to advocate 
for,160 especially in light of a presidential administration dedicated to 
rollback environmental measures.161 Failure to act on the approval of 
AquAdvantage salmon places the United States atop a very slippery slope 
that descends into a food system completely dependent on lab concoctions 
and processing plants, all at the risk of a healthy environment. We cannot 
manufacture an entire ecosystem to compensate for the impending damage 
caused by allowing genetically engineered salmon now. 
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